End-of-day quote
Shanghai S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
21.87
CNY
|
+2.15%
|
|
+3.21%
|
+19.84%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,570
|
12,347
|
42,112
|
32,238
|
20,288
|
24,128
|
-
|
-
|
Enterprise Value (EV)
1 |
10,570
|
12,347
|
42,112
|
32,238
|
20,288
|
24,128
|
24,128
|
24,128
|
P/E ratio
|
31.2
x
|
18.4
x
|
9.92
x
|
5.57
x
|
15.6
x
|
12.9
x
|
10.4
x
|
9.32
x
|
Yield
|
0.97%
|
2.27%
|
1.32%
|
3.45%
|
3.29%
|
5.12%
|
4.01%
|
9.05%
|
Capitalization / Revenue
|
0.59
x
|
0.67
x
|
1.78
x
|
1.06
x
|
0.72
x
|
0.81
x
|
0.77
x
|
0.74
x
|
EV / Revenue
|
0.59
x
|
0.67
x
|
1.78
x
|
1.06
x
|
0.72
x
|
0.81
x
|
0.77
x
|
0.74
x
|
EV / EBITDA
|
7.3
x
|
6.59
x
|
5.92
x
|
3.25
x
|
5.32
x
|
5.02
x
|
4.67
x
|
4.19
x
|
EV / FCF
|
-
|
-
|
10.4
x
|
7.06
x
|
-21.1
x
|
8.23
x
|
5.02
x
|
5.1
x
|
FCF Yield
|
-
|
-
|
9.58%
|
14.2%
|
-4.73%
|
12.2%
|
19.9%
|
19.6%
|
Price to Book
|
1.3
x
|
1.31
x
|
3.05
x
|
1.6
x
|
0.99
x
|
1.09
x
|
1
x
|
0.97
x
|
Nbr of stocks (in thousands)
|
1,028,233
|
1,119,393
|
1,111,725
|
1,111,671
|
1,111,675
|
1,103,254
|
-
|
-
|
Reference price
2 |
10.28
|
11.03
|
37.88
|
29.00
|
18.25
|
21.87
|
21.87
|
21.87
|
Announcement Date
|
4/28/20
|
4/11/21
|
3/4/22
|
3/20/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,039
|
18,317
|
23,607
|
30,311
|
28,105
|
29,673
|
31,432
|
32,680
|
EBITDA
1 |
1,448
|
1,873
|
7,117
|
9,905
|
3,810
|
4,802
|
5,162
|
5,752
|
EBIT
1 |
483.2
|
773.6
|
5,901
|
8,213
|
1,747
|
2,487
|
3,163
|
3,420
|
Operating Margin
|
2.68%
|
4.22%
|
25%
|
27.09%
|
6.22%
|
8.38%
|
10.06%
|
10.47%
|
Earnings before Tax (EBT)
1 |
456.5
|
706.6
|
5,390
|
7,871
|
1,716
|
2,420
|
3,074
|
3,315
|
Net income
1 |
302.5
|
623.9
|
4,247
|
5,852
|
1,379
|
1,878
|
2,328
|
2,596
|
Net margin
|
1.68%
|
3.41%
|
17.99%
|
19.31%
|
4.91%
|
6.33%
|
7.41%
|
7.94%
|
EPS
2 |
0.3300
|
0.6000
|
3.820
|
5.210
|
1.170
|
1.700
|
2.101
|
2.347
|
Free Cash Flow
1 |
-
|
-
|
4,035
|
4,566
|
-960.6
|
2,933
|
4,804
|
4,730
|
FCF margin
|
-
|
-
|
17.09%
|
15.06%
|
-3.42%
|
9.88%
|
15.28%
|
14.47%
|
FCF Conversion (EBITDA)
|
-
|
-
|
56.71%
|
46.09%
|
-
|
61.07%
|
93.06%
|
82.23%
|
FCF Conversion (Net income)
|
-
|
-
|
95.03%
|
78.02%
|
-
|
156.15%
|
206.31%
|
182.2%
|
Dividend per Share
2 |
0.1000
|
0.2500
|
0.5000
|
1.000
|
0.6000
|
1.120
|
0.8767
|
1.980
|
Announcement Date
|
4/28/20
|
4/11/21
|
3/4/22
|
3/20/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
4,035
|
4,566
|
-961
|
2,933
|
4,804
|
4,730
|
ROE (net income / shareholders' equity)
|
3.75%
|
7.31%
|
36.8%
|
34.8%
|
6.73%
|
8.3%
|
9.66%
|
10.3%
|
ROA (Net income/ Total Assets)
|
1.12%
|
2.16%
|
13.5%
|
14.9%
|
3.2%
|
3.9%
|
4.68%
|
5%
|
Assets
1 |
26,957
|
28,860
|
31,542
|
39,174
|
43,095
|
48,163
|
49,772
|
51,920
|
Book Value Per Share
2 |
7.920
|
8.450
|
12.40
|
18.10
|
18.50
|
20.10
|
21.90
|
22.60
|
Cash Flow per Share
2 |
1.010
|
2.150
|
4.800
|
6.190
|
1.310
|
4.100
|
4.660
|
3.620
|
Capex
1 |
1,054
|
851
|
1,302
|
2,318
|
2,414
|
2,423
|
2,136
|
1,196
|
Capex / Sales
|
5.84%
|
4.65%
|
5.51%
|
7.65%
|
8.59%
|
8.17%
|
6.8%
|
3.66%
|
Announcement Date
|
4/28/20
|
4/11/21
|
3/4/22
|
3/20/23
|
4/1/24
|
-
|
-
|
-
|
Last Close Price
21.87
CNY Average target price
24.09
CNY Spread / Average Target +10.16% Consensus |
1st Jan change
|
Capi.
|
---|
| +19.84% | 3.26B | | +4.70% | 103B | | +2.40% | 65.6B | | +42.86% | 39.06B | | +16.96% | 37.58B | | +6.96% | 33.26B | | +7.89% | 19.22B | | +12.12% | 16.83B | | +12.08% | 15.03B | | +17.69% | 14.96B |
Other Commodity Chemicals
|